BKR signs $210 cash deal for Chart, backed by $14.9B financing
Rhea-AI Filing Summary
Material event: On 28 Jul 2025 Baker Hughes (BKR) entered into a definitive Agreement and Plan of Merger with Chart Industries (Chart) to acquire 100 % of Chart for $210.00 cash per share. Tango Merger Sub will merge into Chart, which will survive as an indirect wholly-owned subsidiary.
Key terms
- Boards of both companies unanimously approved the transaction.
- Conditions include Chart shareholder approval, HSR expiration and other antitrust clearances, no governmental restraints, accuracy of reps & warranties and absence of a Chart material adverse effect.
- No financing condition. Baker Hughes obtained a 364-day senior unsecured bridge facility up to $14.9 bn from Goldman Sachs & Morgan Stanley to fund consideration and costs; commitments shrink as permanent debt or asset-sale proceeds are raised.
- Termination fees: Chart pays Baker Hughes $250 m in certain scenarios; Baker Hughes pays Chart $500 m if the deal is blocked or not closed by the outside date (one year plus up to two automatic six-month extensions).
- Baker Hughes will fund Flowserve’s prior break-up fee and expenses totalling $258 m, reimbursable by Chart if the merger terminates under specified triggers.
Joint press release (Ex. 99.1) and investor presentation (Ex. 99.2) were issued on 29 Jul 2025. The filing contains customary forward-looking-statement disclaimers.
Positive
- Strategic expansion: Immediate entry into Chart’s LNG and cryogenics portfolio aligns with Baker Hughes’ energy-transition growth priorities.
- Unanimous board approval and lack of financing condition reduce execution uncertainty compared with typical leveraged buyouts.
- Committed $14.9 bn bridge facility demonstrates strong banking support, preserving deal certainty.
Negative
- Higher leverage: Bridge financing could materially increase Baker Hughes’ debt until permanent funding is secured.
- Regulatory & antitrust risk: Large $500 m reverse break-up fee highlights potential for delayed or blocked closing.
- Termination payments: Up-front $258 m Flowserve break-up payment adds cash outflow and contingent recovery risk.
Insights
TL;DR All-cash $210/share deal adds high-growth LNG & cryogenics assets, but raises leverage and regulatory risk.
The acquisition gives Baker Hughes immediate scale in cryogenic equipment and LNG infrastructure, areas aligned with its energy transition strategy. A bridge of up to $14.9 bn signals access to deep capital markets and the absence of a financing condition reduces closing risk. Yet the sizeable debt load will elevate pro-forma leverage until permanent funding is arranged, and a $500 m reverse break-up fee underscores antitrust uncertainty. The outside date structure (up to two years) provides time but prolongs execution risk. Overall impact seen as strategically positive but execution-dependent.
TL;DR Bridge loan supports deal, but temporary leverage spike and termination-fee exposure weaken near-term credit profile.
The 364-day unsecured bridge allows Baker Hughes to close without capital-markets timing risk, yet could inflate gross debt by nearly $15 bn if not refinanced quickly. Management intends permanent bonds and term loans, but market conditions will dictate pricing. The $250 m payment to Flowserve plus potential $500 m reverse fee add contingent liabilities. Covenants appear standard; no incremental liens. Rating agencies will likely focus on pro-forma EBITDA coverage and pace of deleveraging through synergies and asset sales.